Safety and efficacy of siddha medicine preparation in the management of COVID-19: A prospective randomised open label study

World Health O, 2020 Maheshkumar, 2020, Angiotensin-converting enzyme 2 (ACE2): COVID 19 gate way to multiple organ failure syndromes, Respir Physiol Neurobiol Rabaan, 2020, SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic, Ann Clin Microbiol Antimicrob, 19, 1, 10.1186/s12941-020-00384-w Thileepan, 2018, Literature review of suram (fever) in siddha medicine, J Res Tradit Med, 4, 21, 10.5455/JRTM.2018/298118 Zhu, 2020, A novel coronavirus from patients with pneumonia in China, 2019, N Engl J Med, 382, 727, 10.1056/NEJMoa2001017 Rathinam, 2020, Analogy of Kaba Suram with COVID-19 symptoms-A siddha literature review, Int J Ayurvedic Med, 11, 616, 10.47552/ijam.v11i4.1674 Srivastava, 2021, Trials, 22, 130, 10.1186/s13063-021-05041-x Chitra, 2021, An open clinical evaluation of selected siddha regimen in expediting the management of Covid-19 –a randomized controlled study, J Ayurveda Integr Med, 13, 100397, 10.1016/j.jaim.2021.01.002 Srivastava, 2021, Trials, 22, 1, 10.1186/s13063-020-04976-x Meenakumari, 2021, Clinical outcomes among COVID-19 patients managed with modern and traditional Siddha medicine-a retrospective cohort study, Chennai, Tamil Nadu, India, 2020, J Ayurveda Integr Med, 13, 100470, 10.1016/j.jaim.2021.06.010 Priya, 2020, AYUSH for COVID-19: science or superstition?, Indian J Publ Health, 64, 105, 10.4103/ijph.IJPH_500_20 Sharifpour, 2020, C-Reactive protein as a prognostic indicator in hospitalized patients with COVID-19, PLoS One, 15, 10.1371/journal.pone.0242400